Inventor · disambiguated record
Randall Moreadith
Also filed as: MOREADITH RANDALL · MOREADITH RANDALL W
16 granted patents·9 pending applications·85 citations·filing 1997–2025
92Inventor score
Files withSERINA THERAPEUTICS INC15SERINA THERAPEUTICS AL INC5SERINA THERAPEUITCS INC1THROMB X N V1UNIV TEXAS1
Top patents by PatentIndex Score
25 records- 0194US8383093B1Subcutaneous delivery of poly(oxazoline) conjugatesSERINA THERAPEUTICS INC·Filed 2012·Granted Feb 26, 2013·21 cites·17 claims
- 0292US11944618B2Subcutaneous delivery of polymer conjugates of therapeutic agentsSERINA THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·1 cites·13 claims
- 0392US11298350B2Subcutaneous delivery of polymer conjugates of therapeutics agentsSERINA THERAPEUTICS INC·Filed 2019·Granted Apr 12, 2022·3 cites·22 claims
- 0489US8597633B2Subcutaneous delivery of poly(oxazoline) conjugatesSERINA THERAPEUTICS INC·Filed 2013·Granted Dec 3, 2013·8 cites·23 claims
- 0587US11224595B2Subcutaneous delivery of poly(oxazoline) polymer conjugatesSERINA THERAPEUTICS INC·Filed 2019·Granted Jan 18, 2022·1 cites·20 claims
- 0687US10426768B2Subcutaneous delivery of polymer conjugates of therapeutic agentsSERINA THERAPEUTICS INC·Filed 2017·Granted Oct 1, 2019·4 cites·20 claims
- 0783US12383626B2Polyoxazoline-drug conjugates with novel pharmacokinetic propertiesSERINA THERAPEUTICS AL INC·Filed 2024·Granted Aug 12, 2025·0 cites·20 claims
- 0882US12383625B2Polyoxazoline-drug conjugates with novel pharmacokinetic propertiesSERINA THERAPEUTICS AL INC·Filed 2024·Granted Aug 12, 2025·0 cites·20 claims
- 0977US10314837B2Subcutaneous delivery of poly(oxazoline) polymer conjugatesSERINA THERAPEUTICS INC·Filed 2016·Granted Jun 11, 2019·1 cites·19 claims
- 1077US2024108750A1Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including sameSERINA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1176US11766432B2Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the sameSERINA THERAPEUTICS INC·Filed 2019·Granted Sep 26, 2023·1 cites·31 claims
- 1275US6632934B1MORC gene compositions and methods of useUNIV TEXAS·Filed 1999·Granted Oct 14, 2003·36 cites·2 claims
- 1374US12233132B2Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including sameSERINA THERAPEUTICS INC·Filed 2022·Granted Feb 25, 2025·0 cites·22 claims
- 1471US2024016798A1Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the sameSERINA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1566US12485181B2Polyoxazoline-drug conjugates with novel pharmacokinetic propertiesSERINA THERAPEUTICS AL INC·Filed 2020·Granted Dec 2, 2025·0 cites·24 claims
- 1664US11065340B2Polyoxazoline antibody drug conjugatesSERINA THERAPEUTICS INC·Filed 2018·Granted Jul 20, 2021·0 cites·10 claims
- 1764US2024277821A1Targeting of antigen-presenting cells by nanoparticles containing polyoxazoline-lipid conjugatesSERINA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1864US2014112880A1Subcutaneous delivery of poly(oxazoline) polymer conjugatesSERINA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1963US2025017857A1Poly(oxazoline) conjugates with pendant cationic groups and lipid nanoparticles and polyplexes including sameSERINA THERAPEUTICS AL INC·Filed 2024·Application pending·0 cites
- 2051US2025352664A1Meth0ds of administering lipid nanoparticles including poly(ethyloxazoline)-lipid conjugates without raising immune response to polymerSERINA THERAPEUTICS AL INC·Filed 2025·Application pending·0 cites
- 2148US10071168B2Polyoxazoline antibody drug conjugatesSERINA THERAPEUTICS INC·Filed 2015·Granted Sep 11, 2018·0 cites·24 claims
- 2248US2014271527A1Subcutaneous delivery of polymer conjugates of therapeutic agentsSERINA THERAPEUITCS INC·Filed 2012·Application pending·0 cites
- 2345US6103523APluripotent rabbit cell lines and method of makingTHROMB X N V·Filed 1997·Granted Aug 15, 2000·9 cites·3 claims
- 2441US2003124720A1Conditioned culture mediaFiled 2002·Application pending·0 cites
- 2539US2004053406A1Pluripotent embryonic stem (es) cell lines, improved methods for their production, and their use for germ line transmission and for the generation of genetically modified animalsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Randall Moreadith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →